98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/WNP.0000000000000581 | DOI Listing |
J Clin Neurophysiol
July 2019
Department of Neurology, Epilepsy Center and Neurocritical Care Program at UC Neuroscience Institute, University of Cincinnati (UC) College of Medicine, Cincinnati, Ohio, U.S.A.
Boll Soc Ital Biol Sper
January 1993
Istituto di Clinica Medica, Università degli Studi di Ancona.
Aim of our study was estimating if TSH could influence the timing of ANP release. About it we observed 70 male subjects: 40 were euthyroid patients aged 42 +/- 5 years (group A); 20 patients treated by thyroxine in doses sufficient for inhibiting TSH release, aged 45 +/- 7 years (group B). A third group (C) was composed by 10 subjects with high basal levels of serum T3 and T4 with no thyrostatic therapy, aged 40 +/- 9 years.
View Article and Find Full Text PDF